MR-guided radiotherapy
HCA Healthcare UK invests £15million to introduce advanced MR-guided radiotherapy with Elekta Unity MR Linac
Read the latest news stories and press releases from HCA Healthcare UK in London, Birmingham and Manchester.
Leading private healthcare provider HCA Healthcare UK has announced that it is offering amyloid-targeting therapies for patients diagnosed with early-stage Alzheimer's disease. The therapies available include lecanemab and donanemab - the first two disease-modifying treatments for Alzheimer’s disease licensed for use in Great Britain.